Some of you have contacted us asking about the Warning Letter from the U.S. Food and Drug Administration (FDA). The issues with the FDA were the result of not having some paperwork in place. In other words, the issues were clerical, not fiscal. All is now resolved and Mezotrace is now in good standing with the FDA.
